Summary
Six synthetic peptides corresponding to regions of bovine enterovirus (BEV), strain VG-5-27, elicited antibodies in mice which reacted with the virus in various assays. These antibodies have been characterised on the basis of their ability to (1) neutralize the virus, (2) bind to the intact virus particle in an immunoprecipitation test, (3) react with the denatured viral proteins, and (4) give immunofluorescent staining of virus infected cells. We have also determined the proportion of antipeptide antibody which binds to the virus in each case. All of the sera immunoprecipitated the virus and neutralized its activty to varying extents. Two of the sera specific for VP 1 sequences failed to react with denatured VP 1 whereas all the other antisera reacted with their respective parental proteins. All of the sera reacted with VG-5-27 infected cells in an immunofluorescence test. The proportion of antibodies to each peptide recognizing intact virus was variable and did not appear to correlate with neutralizing activity. In addition, the ability of each of the sera to react with and neutralize three other strains of the virus was analysed. With one of these strains significant cross-neutralization was observed.
Similar content being viewed by others
References
Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F (1989) The three dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337: 709–716
Alexander H, Johnson DA, Rosen J, Jerabek L, Green N, Weismann IL, Lerner RA (1983) Mimicking the alloantigenicity of proteins with chemically synthesised peptides differing in single amino acids. Nature 306: 697–699
Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, Parry NR (1989) Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J Gen Virol 70: 1483–1491
Bittle JL, Houghten RA, Alexander H, Shannock TM, Sutcliffe KG, Lerner RA, Rowlands DJ, Brown F (1982) Protection against foot-and-mouth disease virus by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298: 30–33
Boege U, Kobasha D, Onodera S, Palmenberg A, Scraba D (1991) Characterization of Mengo virus neutralization epitopes. Virology 181: 1–13
Chow M, Yabrov R, Bittle J, Hogle J, Baltimore D (1985) Synthetic peptides from four separate regions of poliovirus type 1 capsid protein VP 1 induce neutralizing antibodies. Proc Natl Acad Sci USA 82: 910–914
Colman PM, Laver WG, Varghese JN, Baker AT, Tulloch PA, Air GM, Webster PG (1987) Three dimensional structure of a complex of anitbody with influenza virus neuraminidase. Nature 326: 358–363
Earle JAP, Skuce RA, Fleming CS, Hoey EM, Martin SJ (1988) Complete nucleotide sequence of a bovine enterovirus. J Gen Virol 69: 253–263
Emini EA, Jameson BA, Wimmer E (1983) Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature 304: 699–703
Emini EA, Jameson BA, Wimmer E (1984) Identification of a new neutralizing antigenic site on poliovirus coat protein VP2. J Virol 52: 719–721
Ferguson M, Evans DMA, MaGrath EI, Minor PD, Almond JW, Shild GC (1985) Induction by synthetic peptides of broadly reactive, type specific neutralizing antibody to poliovirus type 3. Virology 143: 505–515
Francis MJ, Hastings GZ, Sangar DV, Clark RP, Syred A, Rowlands DJ, Brown F (1987) A synthetic peptide which elicits neutralizing antibody to human rhinovirus type 2. J Gen Virol 68: 2687–2691
Hoey EM, Martin SJ (1974) A possible precursor containing RNA of a bovine enterovirus: the provirion II. J Gen Virol 24: 515–524
Hogle JM, Chow M, Filman DJ (1985) Three dimensional structure of poliovirus at 2.9 Å resolution. Science 229: 1358–1365
Houghten RA (1985) General method for the rapid synthesis of large numbers of peptides: specificity of an antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 82: 5131–5135
Jameson BA, Bonin J, Murray MG, Wimmer E, Kew O (1985) Peptide-induced neutralizing antibodies to poliovirus. In: Lerner R, Channock RM, Brown F (eds) Vaccines 85. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 197–198
Knowles NJ, Barnett ITR (1985) A serological classification of bovine enteroviruses. Arch Virol 83: 141–145
Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T 4. Nature 227: 680–685
Luo M, Vriend G, Kramer G, Minor I, Arnold E, Rossmann MG, Boege V, Scraba DG, Duke GM, Palmenberg AC (1987) The atomic structure of Mengo virus at 3.0 Å resolution. Science 235: 182–191
McCahon D, Crowther JR, Belsham GJ, Kitson JDA, Duchesne M, Have P, Meloen RH, Morgan DO, De Simone F (1989) Evidence for at least four antigenic sites of type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol 70: 639–645
Martin SJ, Johnson MD, Clements JB (1970) Purification and characterization of a bovine enterovirus. J Gen Virol 7: 103–113
Minor PD, Schild GC, Bootman J, Evans DMA, Ferguson M, Reeve P, Spitz M, Stanway G, Cannon AJ, Hauptmann R, Clarke BLD, Mountford RC, Almond JW (1983) Location and primary structure of a major antigenic site for poliovirus neutralization. Nature 301: 674–679
Minor PD, Ferguson M, Evans DMA, Almond JW, Icenogle JP (1986) Antigenic structure of poliovirus of serotypes 1, 2, and 3. J Gen Virol 67: 1283–1291
Parry NR, Syred A, Rowlands DJ, Brown F (1988) A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles. Immunology 64: 567–572
Parry NR, Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F (1989) Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. J Gen Virol 70: 1493–1503
Pfaff E, Mussgay M, Bohm HO, Schulz GE, Schaller H (1982) Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J 1: 869–874
Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht HJ, Johnson JE, Kamer G, Luo M, Mosser AG, Rueckert RR, Sherry B, Vriend G (1985) Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317: 145–153
Rowlands DJ, Clarke BE, Carrol AR, Brown F, Nicholson BH, Bittle JL, Houghten RA, Lerner RA (1983) Chemical basis of antigenic variation on foot-and-mouth disease virus. Nature 306: 694–697
Sherry B, Rueckert RR (1985) Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol 53: 137–143
Sherry B, Mosser AG, Colonno RJ, Rueckert RR (1986) Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 57: 246–257
Smyth MS, Hoey EM, Trudgett A, Martin SJ, Brown F (1990) Chemically synthesized peptides elicit neutralizing antibody to bovine enterovirus. J Gen Virol 71: 231–234
Xie Ql, McCahon D, Crowther JR, Belsham GJ, McCullough KC (1987) Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate sites. J Gen Virol 68: 1637–1647
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smyth, M.S., Trudgett, A., Hoey, E.M. et al. Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides. Archives of Virology 126, 21–33 (1992). https://doi.org/10.1007/BF01309681
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01309681